Latest & greatest articles for hypertension

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on hypertension or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on hypertension and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for hypertension

1. Hypertension Canada's 2020 hypertension guidelines for pharmacists: an update.

- to 30-minute intervals during the day and night. BP values considered high* = mean awake SBP =135 mmHg or DBP =85 mmHg or mean 24-hour SBP =130 mmHg or DBP =80 mmHg (Grade C) Preferred out-of-office methods for diagnosis HBPM Home blood pressure monitoring is a self-monitoring method, which requires the patient to measure their BP twice in the morning and evening for 7 days. BP values considered high* = SBP =135 mmHg or DBP =85 mmHg (Grade C) Hypertension Canada 2020 guidelines measurement (...) of Cardiology 2 or on Hyperten- sion Canada’s website (www.hypertension.ca). What’s new Terminology Automated office blood pressure (AOBP) is still the preferred method of measurement for measuring blood pressure (BP) in the office. Where this method is not possible, office BP measurement (OBPM, previously known as non-AOBP) is suggested. Table 1 outlines the definitions and preferred meth- ods of BP measurement according to the 2020 Hypertension Canada guidelines. Home BP monitoring (HBPM) is recom- mended

2021 CPG Infobase

2. Femoral artery block (FAB) attenuates thigh tourniquet-induced hypertension: a prospective randomized, double-blind, placebo-controlled trial

of the inguinal crease under ultrasound guidance. Both groups received preoperative popliteal sciatic and saphenous nerve blocks for analgesia and a standardized general anesthetic. Esmolol was administered if systolic blood pressure rose >30% above baseline. Incidence of TH was the primary outcome. Results: TH was present in 93.3% of sham patients versus 33.3% of block patients. Mean systolic pressure at 120 min and 150 min of tourniquet time was significantly higher in the sham group compared with the block (...) Femoral artery block (FAB) attenuates thigh tourniquet-induced hypertension: a prospective randomized, double-blind, placebo-controlled trial Femoral artery block (FAB) attenuates thigh tourniquet-induced hypertension: a prospective randomized, double-blind, placebo-controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable

2021 EvidenceUpdates

3. Hypertension and pregnancy

to, *:First line drugs, ^: Not on QH List of approved medicines (LAM), ": Second line drugsQueensland Clinical Guideline: Hypertensive disorders of pregnancy Refer to online version, destroy printed copies after use Page 5 of 32 Abbreviations ACE Angiotensin Converting Enzyme AFI Amniotic fluid index APLS Antiphospholipid syndrome BMI Body Mass Index BP Blood pressure CI Confidence Interval CMACE Centre for Maternal and Child Enquiries CTG Cardiotocograph dBP Diastolic blood pressure DIC Disseminated (...) intravascular coagulation DVP Deepest vertical pocket FBC Full blood count FHR Fetal heart rate GA General anaesthesia HDP Hypertensive disorders of pregnancy GP General Practitioner HELLP Haemolysis, Elevated Liver enzymes and Low Platelet count IUGR/FGR Intrauterine growth restriction/Fetal growth restriction LAM List of approved medicines LDH Lactate dehydrogenase LFT Liver function test sBP Systolic blood pressure SLE Systemic lupus erythematosus RR Relative risk SpO 2 Saturation of peripheral oxygen

2021 Queensland Health

4. Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study Full Text available with Trip Pro

Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study Clinical outcomes of COVID-19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features (...) -19 following the use of angiotensin-converting enzyme inhibitors or angiotensin-receptor blockers among patients with hypertension in Korea: a nationwide study , , , , , Affiliations Expand Affiliations 1 School of Pharmacy, Sungkyunkwan University, Suwon, Korea. 2 Division of Infectious Diseases, Department of Social and Preventive Medicine, Hallym University College of Medicine, Chuncheon, Korea. 3 Lemuel Shattuck Hospital, Boston, MA, USA. 4 Brigham and Women's Hospital, Boston, MA, USA. 5

2021 EvidenceUpdates

5. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial

Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial - PubMed This site needs JavaScript to work properly. Please enable it to take (...) Actions Cite Display options Display options Format Share Permalink Copy Page navigation Eur Heart J Actions . 2020 Nov 24;ehaa696. doi: 10.1093/eurheartj/ehaa696. Online ahead of print. Standardized exercise training is feasible, safe, and effective in pulmonary arterial and chronic thromboembolic pulmonary hypertension: results from a large European multicentre randomized controlled trial , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Affiliations Expand Affiliations 1 Centre

2020 EvidenceUpdates

6. Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial

.-H.Y.). PMID: 33019798 DOI: Item in Clipboard Full-text links Cite Display options Display options Format Abstract Background: Masked hypertension is associated with adverse cardiovascular outcomes. Nonetheless, no randomized controlled trials exist in the treatment of masked hypertension. The aim of this randomized, placebo-controlled trial was to investigate the efficacy and safety of blood pressure (BP)-lowering treatment with a Chinese herbal formula, gastrodia-uncaria granules, in patients (...) with masked hypertension. Registration: URL: https://www.clinicaltrials.gov; Unique identifier: . Keywords: blood pressure monitoring, ambulatory; masked hypertension; medicine, traditional Chinese; randomized controlled trial. Similar articles Wei FF, Li Y, Zhang L, Shan XL, Cheng YB, Wang JG, Yang CH, Staessen JA. Wei FF, et al. Am J Hypertens. 2016 Mar;29(3):326-31. doi: 10.1093/ajh/hpv106. Epub 2015 Jul 6. Am J Hypertens. 2016. PMID: 26150543 Clinical Trial. Shimada K, Ogihara T, Saruta T, Kuramoto K

2020 EvidenceUpdates

7. The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis Full Text available with Trip Pro

-aldosterone system (RAAS) inhibitors, including angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are one of the most prescribed antihypertensive medications. Previous studies showed RAAS inhibitors increase the expression of ACE2, a cellular receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which provokes a concern that the use of ACEI and ARB in hypertensive individuals might lead to increased mortality and severity of coronavirus disease (...) The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis The use of renin-angiotensin-aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID-19 patients: A systematic review and meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard

2020 EvidenceUpdates

8. High Blood Pressure in Children and Adolescents: Screening

pressure; however, many children identified as having elevated blood pressure will not have hypertension. One study was done in a hypertension clinic in Greece, possibly limiting generalizability to a primary care population in the United States. The other study took place in a high school clinic . Association With Adult Hypertension and Cardiovascular Disease Ten longitudinal studies provided evidence on the association between elevated blood pressure in childhood and adulthood (7 studies), carotid (...) and that the balance of benefits and harms cannot be determined. How Does Evidence Fit With Biological Understanding? The proportion of children with primary hypertension who revert to normal blood pressure over time, without any intervention, and those who will continue to have hypertension in adulthood is unknown. Persistent elevation of blood pressure in adults is an established risk factor for cardiovascular and cerebrovascular disorders and renal impairment. However, these conditions are often distant future

2020 U.S. Preventive Services Task Force

9. Diagnosis of hypertension using ambulatory blood pressure monitoring in patients with clinic blood pressure ? 140/90mmHg and ? 180/110mmHg

Diagnosis of hypertension using ambulatory blood pressure monitoring in patients with clinic blood pressure ? 140/90mmHg and ? 180/110mmHg 1 Public Summary Document Application No. 1572 – Diagnosis of hypertension using ambulatory blood pressure monitoring in patients with clinic blood pressure = 140/90mmHg and = 180/110mmHg Applicant: High Blood Pressure Research Council of Australia Inc. Date of MSAC consideration: MSAC 78 th Meeting, 3 April 2020 Context for decision: MSAC makes its advice (...) to comparative safety, clinical effectiveness and cost-effectiveness, MSAC supported MBS funding of diagnosis of hypertension using ambulatory blood pressure monitoring (ABPM) in patients with clinic blood pressure =140/90 mmHg and =180/110 mmHg on the basis that ABPM is the accepted gold standard for the diagnosis of high blood pressure in primary care. MSAC accepted that ABPM was cost-effective, but advised that the proposed fee should not include the cost of the consumables. MSAC was concerned

2020 Medical Services Advisory Committee

10. Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis Full Text available with Trip Pro

Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis Severity and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. COVID-19 is an emerging, rapidly evolving (...) and mortality of COVID 19 in patients with diabetes, hypertension and cardiovascular disease: a meta-analysis , , , , , , , Affiliations Expand Affiliations 1 Departamento de Medicina Preventiva, Escola Paulista de Medicina, Universidade Federal de São Paulo, Rua Botucatu, n° 740, Vila Clementino, São Paulo, SP CEP 04023-062 Brazil. 2 Sociedade Brasileira de Diabetes-SBD, Rua Afonso Braz, 579, Salas 72/74, Vila Nova Conceição, São Paulo, SP CEP 04511-011 Brazil. 3 Programa de Pós-Graduação Em Endocrinologia

2020 EvidenceUpdates

11. Niraparib (Zejula): reports of severe hypertension and posterior reversible encephalopathy syndrome (PRES), particularly in early treatment

in blood pressure during treatment, manage hypertension with antihypertensives and if necessary, consider treatment interruption and subsequent adjustment of the niraparib dose as advised in discontinue niraparib in case of hypertensive crisis or if medically significant hypertension cannot be adequately controlled with antihypertensive therapy in cases of PRES, discontinue niraparib and treat specific symptoms including hypertension report any suspected adverse drug reactions associated with niraparib (...) cookies. You can at any time. Hide Show or hide search Search on GOV.UK Search National restrictions in England from 5 November Take action now for new rules in 2021 Niraparib (Zejula▼): reports of severe hypertension and posterior reversible encephalopathy syndrome (PRES), particularly in early treatment Increase the frequency of blood pressure monitoring to at least weekly for the first 2 months, and then monitor monthly for the first year and periodically thereafter during treatment, following

2020 MHRA Drug Safety Update

12. The effectiveness of Baduanjin exercise for hypertension: a systematic review and meta-analysis of randomized controlled trials Full Text available with Trip Pro

for cardiovascular morbidity and mortality. Rigorously designed RCTs that carry out longer follow-up and address patient-important outcomes remain warranted. Trial registration PROSPERO Registration number: . Background Hypertension is one of the most prevalent conditions in the world and is commonly regarded as one of the main contributors to cardiovascular morbidity [ ] . High blood pressure (HBP) affects over 1.39 billion people around the world and could lead to an estimated 9.4 million deaths per year (...) randomized controlled trials (RCTs) reported in English or Chinese assessing EB for hypertension. (2) Type of participant: Patients with the following definition of HBP were included [ , ]: systolic blood pressure (SBP) ≥140 mm Hg or diastolic blood pressure (DBP) ≥90 mm Hg; or a previous physician diagnosis of hypertension. We placed no restrictions on age, sex, race, or duration of hypertension. (3) Types of intervention: EB alone or EB combined with either routine treatment (like antihypertensive

2020 BMC complementary medicine and therapies

13. The Effect of Calcium Channel Blockers on Moderate or Severe Albuminuria in Diabetic, Hypertensive Patients Full Text available with Trip Pro

. Results: We analyzed data from 2113 trial participants with hypertension and diabetes mellitus who had the equivalent of ≥30 mg/day of urinary albumin excretion. Inhibitors of the renin-angiotensin system were more effective than calcium channel blockers in decreasing albuminuria (standardized difference in means -0.442; confidence interval, -0.660 to -0.225; P < .001). This finding was independent of the blood pressure response to treatment. There was no difference between the 2 drug classes (...) Hypertens. 2004 May;13(3):319-24. doi: 10.1097/00041552-200405000-00009. Curr Opin Nephrol Hypertens. 2004. PMID: 15073491 Review. Fici F, Ari Bakir E, Ilkay Yüce E, Kanuncu S, Makel W, Tarim BA, Robles NR. Fici F, et al. High Blood Press Cardiovasc Prev. 2020 Feb;27(1):43-49. doi: 10.1007/s40292-020-00358-1. Epub 2020 Jan 9. High Blood Press Cardiovasc Prev. 2020. PMID: 31916208 Chaturvedi S, Lipszyc DH, Licht C, Craig JC, Parekh RS. Chaturvedi S, et al. Evid Based Child Health. 2014 Sep;9(3):581-3

2020 EvidenceUpdates

14. SMFM Special Statement: Checklist for postpartum discharge of women with hypertensive disorders

SMFM Special Statement: Checklist for postpartum discharge of women with hypertensive disorders Publications & Guidelines | SMFM.org - The Society for Maternal-Fetal Medicine Navigate | Search Search » » SMFM Special Statement: Checklist for postpartum discharge of women with hype... SMFM Special Statement: Checklist for postpartum discharge of women with hypertensive disorders The Society for Maternal-Fetal Medicine presents a checklist for the postpartum discharge of women with hypertensive (...) disorders and suggests implementation strategies and quality indicators. Tags: , , Categories: © 2000-2020, Society for Maternal-Fetal Medicine. All rights reserved The Pregnancy Meeting is a Trademark of the Society for Maternal-Fetal Medicine. Use of this Web site constitutes acceptance of Stay Connected

2020 Society for Maternal-Fetal Medicine

15. Radiologic Management of Portal Hypertension

biopsy remains the reference standard for the assessment and diagnosis of cirrhosis, hepatic vein catheterization with measurement of the hepatic venous pressure gradient (HVPG) is currently the benchmark technique for determining portal pressure. The HVPG quantifies the degree of portal hypertension due to sinusoidal resistance to blood flow. The HVPG is calculated as the difference between the wedged hepatic venous pressure and the free hepatic venous pressure. A normal HVPG is between 1 and 5 mmHg (...) ; Bill S. Majdalany, MD c ; Charles Y. Kim, MD d ; Osmanuddin Ahmed, MD e ; Sumeet K. Asrani, MD, MSc f ; Brooks D. Cash, MD g ; Jens Eldrup-Jorgensen, MD h ; A. Tuba Kendi, MD i ; Matthew J. Scheidt, MD j ; David M. Sella, MD k ; Karin E. Dill, MD l ; Eric J. Hohenwalter, MD. m Summary of Literature Review Introduction/Background Portal hypertension is a common clinical syndrome, hemodynamically defined by a pathological increase of the portal pressure and by the formation of portal-systemic

2020 American College of Radiology

16. Alcohol intake reduction for controlling hypertension. (Abstract)

Alcohol intake reduction for controlling hypertension. High blood pressure constitutes one of the leading causes of mortality and morbidity all over the world. At the same time, heavy drinking increases the risk for developing cardiovascular diseases, including cardiomyopathy, hypertension, atrial arrhythmias, or stroke. Several studies have already assessed specifically the relationship between alcohol intake and hypertension. However, the potential effect on blood pressure of alcohol intake (...) reduction interventions is largely unknown.To assess the effect of any intervention to reduce alcohol intake in terms of blood pressure decrease in hypertensive people with alcohol consumption compared to a control intervention or no intervention at all. To determine additional effects related to mortality, major cardiovascular events, serious adverse events, or quality of life.The Cochrane Hypertension Information Specialist searched the following databases for randomised controlled trials up to June

2020 Cochrane

17. Effects of the small-sided soccer games on blood pressure in untrained hypertensive adults: A systematic review and meta-analysis of randomized-controlled trials Full Text available with Trip Pro

Effects of the small-sided soccer games on blood pressure in untrained hypertensive adults: A systematic review and meta-analysis of randomized-controlled trials Inplasy Protocol 806 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

18. Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan ― Systematic Review and Network Meta-Analysis ― Full Text available with Trip Pro

, irbesartan, losartan potassium, olmesartan medoxomil, telmisartan, valsartan) in at least 1 arm. Of 763 RCTs identified, 77 met the eligibility criteria; of which, 37 reported mean change in systolic blood pressure (SBP) and diastolic blood pressure (DBP) from baseline in the office setting and were used to construct the network. A fixed-effects model (FEM) showed the effect of each drug vs. the reference, azilsartan. Using the FEM, the mean (95% credible interval) change from baseline in SBP/DBP (...) Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan ― Systematic Review and Network Meta-Analysis ― Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients With Hypertension in Japan ― Systematic Review and Network Meta-Analysis ― Toggle navigation Circulation Reports Online ISSN : 2434-0790 / / / Article overview Hypertension and Circulatory Control Comparative Effectiveness of Angiotensin II Receptor Blockers in Patients

2020 Circulation Reports

19. 5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19. (Abstract)

5 classes of antihypertensive drugs were not linked to positive COVID-19 test results or severe COVID-19. Reynolds HR, Adhikari S, Pulgarin C, et al. Renin-angiotensin-aldosterone system inhibitors and risk of Covid-19. N Engl J Med. 2020;382:2441-8. 32356628.

2020 Annals of Internal Medicine

20. Meta-analysis of the association between new onset hypertension and renal urolithiasis after extracorporeal shock wave lithotripsy therapy Full Text available with Trip Pro

Meta-analysis of the association between new onset hypertension and renal urolithiasis after extracorporeal shock wave lithotripsy therapy Inplasy Protocol 773 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols